Ranger Investment Management L.P. Takes $11.99 Million Position in BWX Technologies, Inc. $BWXT

Ranger Investment Management L.P. purchased a new position in BWX Technologies, Inc. (NYSE:BWXT) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 58,640 shares of the technology company’s stock, valued at approximately $11,991,000.

A number of other large investors also recently bought and sold shares of BWXT. Cannell & Spears LLC grew its position in BWX Technologies by 4.0% in the 1st quarter. Cannell & Spears LLC now owns 1,312 shares of the technology company’s stock valued at $251,000 after acquiring an additional 50 shares during the last quarter. Wedbush Securities Inc. lifted its position in shares of BWX Technologies by 4.3% during the fourth quarter. Wedbush Securities Inc. now owns 1,263 shares of the technology company’s stock worth $218,000 after purchasing an additional 52 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of BWX Technologies by 1.0% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 5,448 shares of the technology company’s stock valued at $942,000 after purchasing an additional 54 shares during the period. Guggenheim Capital LLC grew its holdings in shares of BWX Technologies by 2.2% in the fourth quarter. Guggenheim Capital LLC now owns 2,598 shares of the technology company’s stock worth $449,000 after purchasing an additional 55 shares during the last quarter. Finally, Stratos Wealth Partners LTD. grew its holdings in shares of BWX Technologies by 3.5% in the fourth quarter. Stratos Wealth Partners LTD. now owns 1,979 shares of the technology company’s stock worth $342,000 after purchasing an additional 67 shares during the last quarter. Hedge funds and other institutional investors own 94.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on BWXT shares. Zacks Research lowered shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Truist Financial lifted their price target on shares of BWX Technologies from $205.00 to $212.00 and gave the company a “hold” rating in a research note on Monday, May 11th. Seaport Research Partners upgraded BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price target for the company in a report on Monday, June 22nd. Wells Fargo & Company began coverage on BWX Technologies in a research note on Wednesday, April 1st. They issued an “underweight” rating and a $200.00 price objective on the stock. Finally, JPMorgan Chase & Co. initiated coverage on BWX Technologies in a report on Monday. They set an “overweight” rating and a $230.00 price objective on the stock. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.20.

BWX Technologies Stock Down 4.1%

NYSE:BWXT opened at $169.25 on Wednesday. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33. BWX Technologies, Inc. has a 1-year low of $143.07 and a 1-year high of $241.82. The company has a 50-day moving average of $190.34 and a 200 day moving average of $202.55. The firm has a market cap of $15.50 billion, a PE ratio of 45.25, a price-to-earnings-growth ratio of 3.01 and a beta of 0.74.

BWX Technologies (NYSE:BWXT) last posted its earnings results on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $0.92 by $0.20. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The business had revenue of $860.22 million for the quarter, compared to the consensus estimate of $837.47 million. During the same quarter last year, the firm posted $0.91 EPS. The company’s revenue for the quarter was up 26.1% on a year-over-year basis. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. As a group, research analysts anticipate that BWX Technologies, Inc. will post 4.6 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $209.25, for a total transaction of $505,757.25. Following the transaction, the chief financial officer directly owned 6,884 shares in the company, valued at approximately $1,440,477. This trade represents a 25.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the transaction, the chief executive officer directly owned 202,491 shares in the company, valued at approximately $41,472,181.71. The trade was a 4.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non?defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.